8-K filing — Azenta, Inc. (AZTA)
Filed: 2026-10-07 AccNo: 0001628280-26-065292 Size: 145 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 2.06: Material Impairments Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Needham analyst David Saxon reiterates Azenta (NASDAQ:AZTA) with a Buy and maintains $37 price target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-07 AccNo: 0001628280-26-065292 Size: 145 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 2.06: Material Impairments Item 9.01: Financial Statements and Exhibits
U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo, PacBio and others posted double-digit gains.
U.S. stocks rose Friday; Applied Digital jumped 9.8% after adding 75 MW of AI capacity, while numerous tech stocks posted gains.